GlassScriptPhysician profile
Monique N Le
NPI 1063176816
$2,342.49
in general payments reported to CMS, 2019-2025
9 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $694 · 2023: $640 · 2024: $650 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,178 · Travel and Lodging: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.28 |
| Travel and Lodging | $469.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $774.37 | 2022-2024 | Floseal, Perclot, Preveleak |
| Getinge USA Sales, LLC | $571.16 | 2022-2023 | Vasoview Hemopro 2 |
| Abiomed | $453.50 | 2022-2025 | Impella |
| Angiodynamics, INC. | $177.46 | 2022 | |
| Edwards Lifesciences Corporation | $158.91 | 2022 | |
| Atricure, INC. | $104.82 | 2024 | |
| Medtronic, INC. | $64.69 | 2024-2025 | Avalus |
| Lemaitre Vascular, INC. | $21.22 | 2025 | Restoreflow |
| Ethicon US, LLC | $16.36 | 2024 | Dermabond Prineo, Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.